Bifidobacterium infantis and 2’-Fucosyllactose supplementation in early life may have potential long-term benefits on gut microbiota, intestinal development, and immune function in mice

Published: 19 December 2022| Version 1 | DOI: 10.17632/tcc7hftfdy.1
Contributor:
雅亭 罗

Description

Bifidobacterium infantis and 2’-Fucosyllactose supplementation in early life may have potential long-term benefits on gut microbiota, intestinal development, and immune function in mice

Files

Institutions

Sichuan University

Categories

Mouse

License